Previous 10 |
home / stock / biovf / biovf news
STOCKHOLM , Aug. 22, 2018 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) has appointed Anne Marie de Jonge Schuermans as Head of Sobi's new Technical Operations organisation, bringing together Sobi's Manufacturing Operations/Biological Development & Supply,...
STOCKHOLM , July 2, 2018 /PRNewswire/ -- On 18 July, at 08:00 CET , Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the second quarter 2018. Financial analysts and media are invited to participate in a telephone conference, which will include a presentat...
STOCKHOLM , May 21, 2018 /PRNewswire/ -- Recent data show quality-of-life improvements for patients treated prophylactically with Elocta® and Alprolix®, extended half-life haemophilia therapies. Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) will present da...
STOCKHOLM , April 19, 2018 /PRNewswire/ -- On 26 April, at 08:00 CET , Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the first quarter 2018. Financial analysts and media are invited to participate in a telephone conference, which will include a present...
STOCKHOLM , April 3, 2018 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) has appointed Fredrik Wetterlundh as Head of Human Resources. Fredrik will join Sobi on 9 April 2018 and be part of Sobi's Extended Leadership Team. Fredrik Wetterlundh joins Sobi from Pfizer...
STOCKHOLM , Feb. 26, 2018 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that Henrik Stenqvist will be appointed Chief Financial Officer (CFO) and will join Sobi in late spring. Henrik will be a member of Sobi's Executive Committee. Henrik Stenqvist ...
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval for Swedish Orphan Biovitrum AB's ( OTCPK:BIOVF ) Kineret (anakinra) for patients at least eight months old and weighing at least 10 kg with Still's ...
STOCKHOLM , Feb. 13, 2018 /PRNewswire/ -- On 22 February, at 08:00 CET , Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the fourth quarter and full year 2017. Financial analysts and media are invited to participate in a telephone conference, which will ...
The FDA has accepted Swedish Orphan Biovitrum AB's ( OTCPK:BIOVF ) Investigational New Drug (IND) application for SOBI003, a chemically modified human recombinant sulfamidase, for the potential treatment of mucopolysaccharidosis type IIIA (MPS IIIA), also know as Sanfilippo syndrome type A...
News, Short Squeeze, Breakout and More Instantly...
Swedish Orphan Biovit Ord Company Name:
BIOVF Stock Symbol:
OTCMKTS Market:
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of three abstracts that highlights data from its myelofibrosis treatment option at the American Society of Clin...
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to emapalumab-lzsg being investigated as a pot...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...